One is the breakdown of immune tolerance to the heart mediated by the CTLA-4, PD-1, and LAG-3 pathways, and the other involves the expansion of T cells targeting a common antigen shared by the cancer and the heart (68, 69). This evidence concerns the gene CTLA4 and cancer.